NZSE:ABA

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Abano Healthcare Group

Executive Summary

Abano Healthcare Group Limited provides oral healthcare services in New Zealand and Australia. More Details


Snowflake Analysis

Moderate growth potential and overvalued.

Share Price & News

How has Abano Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ABA is more volatile than 90% of NZ stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: ABA's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of NZ stocks.


Market Performance


7 Day Return

0.6%

ABA

-1.7%

NZ Healthcare

-1.7%

NZ Market


1 Year Return

-8.0%

ABA

13.6%

NZ Healthcare

9.0%

NZ Market

Return vs Industry: ABA underperformed the NZ Healthcare industry which returned 13.6% over the past year.

Return vs Market: ABA underperformed the NZ Market which returned 9% over the past year.


Shareholder returns

ABAIndustryMarket
7 Day0.6%-1.7%-1.7%
30 Day14.3%0.07%0.3%
90 Day91.2%13.9%5.4%
1 Year-8.0%-8.0%16.1%13.6%13.1%9.0%
3 Year-43.8%-49.0%60.4%48.8%47.1%28.2%
5 Year-19.6%-35.5%112.4%87.9%98.3%50.4%

Long-Term Price Volatility Vs. Market

How volatile is Abano Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Abano Healthcare Group undervalued compared to its fair value and its price relative to the market?

1.37x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: ABA (NZ$4.97) is trading above our estimate of fair value (NZ$2.59)

Significantly Below Fair Value: ABA is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ABA is unprofitable, so we can't compare its PE Ratio to the XO Healthcare industry average.

PE vs Market: ABA is unprofitable, so we can't compare its PE Ratio to the NZ market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ABA's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ABA is good value based on its PB Ratio (1.4x) compared to the NZ Healthcare industry average (1.7x).


Next Steps

Future Growth

How is Abano Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

79.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ABA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: ABA is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ABA's is expected to become profitable in the next 3 years.

Revenue vs Market: ABA's revenue (4% per year) is forecast to grow slower than the NZ market (5.6% per year).

High Growth Revenue: ABA's revenue (4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ABA's Return on Equity is forecast to be low in 3 years time (8%).


Next Steps

Past Performance

How has Abano Healthcare Group performed over the past 5 years?

-43.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ABA is currently unprofitable.

Growing Profit Margin: ABA is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ABA is unprofitable, and losses have increased over the past 5 years at a rate of 43.5% per year.

Accelerating Growth: Unable to compare ABA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ABA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).


Return on Equity

High ROE: ABA has a negative Return on Equity (-50.92%), as it is currently unprofitable.


Next Steps

Financial Health

How is Abano Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: ABA's short term assets (NZ$38.3M) do not cover its short term liabilities (NZ$53.0M).

Long Term Liabilities: ABA's short term assets (NZ$38.3M) do not cover its long term liabilities (NZ$252.5M).


Debt to Equity History and Analysis

Debt Level: ABA's debt to equity ratio (173.5%) is considered high.

Reducing Debt: ABA's debt to equity ratio has increased from 102.8% to 173.5% over the past 5 years.

Debt Coverage: ABA's debt is not well covered by operating cash flow (14.2%).

Interest Coverage: ABA is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet


Next Steps

Dividend

What is Abano Healthcare Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ABA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ABA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ABA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ABA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ABA is not paying a notable dividend for the NZ market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ABA's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average management tenure


CEO

Richard Keys

5yrs

Tenure

NZ$584,560

Compensation

Mr. Richard George Keys, BCom, CA has been Chief Executive Officer of Abano Healthcare Group Limited since November 2, 2015. Mr. Keys served as the Chief Financial Officer of Abano Healthcare Group Ltd. (f...


CEO Compensation Analysis

Compensation vs Market: Richard's total compensation ($USD406.17K) is about average for companies of similar size in the NZ market ($USD324.77K).

Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Richard Keys
Chief Executive Officer5yrsNZ$584.56k0.25%
NZ$ 325.9k
Rhys Clark
Chief Financial Officer1.83yrsno datano data
Dennis Surlan
Chief Operating Officer2yrsno datano data
Peter Radich
Chief Information Officerno datano datano data
Kerry Dunphy
General Manager of Marketingno datano datano data
Bridget O'Shannessey
Acting GM People & Capability0.42yrno datano data
Andy Tapper
Acting General Manager of Operations (NZ)no datano data0.20%
NZ$ 258.1k
Fred Calavassy
Clinical Directorno datano datano data
Sophie Harmsworth
General Manager of Strategy & Acquisition (Aus)no datano datano data
Karen Wood
Chief Executive Officer of Aotea Pathologyno datano datano data
David Rogers
Chief Executive Officer of Insight+Ascot Radiologyno datano datano data
Con Balasoglou
Chief Executive Officer of Orthotics Centreno datano datano data

1.9yrs

Average Tenure

Experienced Management: ABA's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Murray Boyte
Independent Deputy Chairmanno dataNZ$87.26k0.065%
NZ$ 84.4k
Philippa Dunphy
Independent Chairman of the Board2.08yrsNZ$139.43k0.11%
NZ$ 141.5k
Michael Schubert
Independent Director0.50yrNZ$2.69kno data
Ginni Mansberg
Independent Director4.25yrsNZ$69.71k0.039%
NZ$ 51.0k
Tracey Batten
Independent Director2.5yrsNZ$80.41k0.020%
NZ$ 25.8k

2.3yrs

Average Tenure

Experienced Board: ABA's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Abano Healthcare Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Abano Healthcare Group Limited
  • Ticker: ABA
  • Exchange: NZSE
  • Founded: 1961
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: NZ$130.623m
  • Shares outstanding: 26.28m
  • Website: https://www.abano.co.nz

Number of Employees


Location

  • Abano Healthcare Group Limited
  • AMP Centre
  • Level 11
  • Auckland
  • 1010
  • New Zealand

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ABANZSE (New Zealand Stock Exchange)YesOrdinary SharesNZNZDJan 1992

Biography

Abano Healthcare Group Limited provides oral healthcare services in New Zealand and Australia. It operates through Dental New Zealand and Dental Australia segments. The company offers a range of general an...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/23 10:36
End of Day Share Price2020/11/23 00:00
Earnings2020/05/31
Annual Earnings2020/05/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.